Our Company

Eureka Therapeutics is a preclinical-stage company developing innovative T cell immunotherapies for the treatment of solid tumors. Our first clinical program for the treatment of liver cancer is projected to enter the clinic in 2017.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text.